Palmitoylethanolamide and Polydatin in Pediatric Irritable Bowel Syndrome

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This will be a randomised, double-blind, placebo-controlled, parallel-arm trial, designed to study the efficacy and safety of co-micronised palmithoylethanolamide/polydatin in pediatric patients (\> 10 years) with Irritable bowel syndrome (IBS)
Epistemonikos ID: 8a75e9d6420b69d14824aba364b82bbf87f5354e
First added on: Feb 19, 2024